Table 2 Medications given to patients alive at discharge*, and outcomes for all patients, according to stroke type
OUTCOMES* | Ischemic | Hemorrhagic | p-value** | Trend p-value |
|---|---|---|---|---|
N (%) | 328 | 366 | - | - |
Modified Rankin score at discharge, % | 0.2 | <0.001 | ||
No disability | 0.9 | 0.2 | ||
No significant disability | 8.5 | 3.4 | ||
Slight disability | 10.7 | 6.2 | ||
Moderate disability, able to walk | 21.8 | 12.0 | ||
Moderate disability, unable to walk | 17.0 | 11.1 | ||
Severe disability | 37.7 | 57.8 | ||
Dead | 3.5 | 9.4 | ||
Modified Rankin score at discharge, mean | 3.81 | 4.78 | <0.001 | |
Discharge status, % | <0.001 | |||
Alive | 81.2 | 50.5 | ||
Dead | 3.6 | 9.4 | ||
Discharged to die | 15.3 | 40.1 | ||
28-day Mortality | 20.3 | 51.0 | <0.001 | |
MEDICATIONS AT DISCHARGE+ | ||||
Anticoagulants in-hospital, % | 2.3 | 0.5 | 0.2 | |
Antidiabetics in-hospital, % | 8.5 | 4.0 | 0.10 | |
Antiplatelets in-hospital, % | 49.5 | 1.5 | <0.001 | |
Cholesterol lowering medications in-hospital, % | 38.9 | 23.6 | 0.001 | |
Antihypertensives, % | 55.7 | 77.5 | <0.001 |